Seok-Soo Byun

Title: Seok-Soo Byun: Innovator in Prostate Cancer Biomarkers

Introduction

Seok-Soo Byun is a prominent inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the area of prostate cancer. His innovative work focuses on the development of biomarker compositions that aid in the diagnosis and prognosis of metastatic prostate cancer.

Latest Patents

Seok-Soo Byun holds a patent for a "Circulating tumor cell based biomarker composition for diagnosis and prognosis of metastatic prostate cancer." This invention relates to a biomarker composition that enhances the detection rate and expression level of a gene combination composed of AR (Androgen receptor), AR-V7 (Androgen receptor variant 7), EpCAM (Epithelial cell adhesion molecule), KRT-19 (Cytokeratin 19), PSA (Prostate specific antigen), and PSMA (Prostate specific membrane antigen) in circulating tumor cells (CTCs) isolated from patients. The gene combination serves as a reliable biomarker for diagnosing prostate cancer and predicting its prognosis, confirming its relevance to the level of malignancy in the disease.

Career Highlights

Throughout his career, Seok-Soo Byun has been associated with notable institutions, including the Inje University Industry-Academic Cooperation Foundation and Seoul National University. His work has been instrumental in advancing the understanding of prostate cancer biomarkers and their clinical applications.

Collaborations

Seok-Soo Byun has collaborated with esteemed colleagues such as Jae Seung Chung and Ki-Ho Han. Their joint efforts have contributed to the development of innovative solutions in cancer diagnostics.

Conclusion

Seok-Soo Byun's contributions to the field of prostate cancer diagnostics through his patented biomarker composition highlight his role as a key innovator. His work not only enhances the understanding of cancer biology but also paves the way for improved diagnostic and prognostic tools in oncology.